Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Japan’s Biggest Drug Store Chains Consolidate Business

This article was originally published in PharmAsia News

Executive Summary

Japanese major drug store chain, Saitama-based Welcia Kanto, will merge with Takada Yakkyoku, a Shizuoka-based drug store operator, to set up a holding company in September. According to February 2007 financial results, Welcia reported sales of ¥87 billion ($296.1 million) with 297 stores located in Saitama prefecture surrounding the Kanto area. Centered in Shizuoka prefecture, Takada Yakkyoku reported sales of ¥29.5 billion (September 2007 results) and 98 drug stores. Japanese drug store businesses are dominated by big holding companies such as Tsuruha Holdings, Matumoto Kyoshi and Allied Hearts Holdings. Competition is expected to increase as supermarkets and convenience stores begin to sell drugs. To gain a competitive edge, mid-sized companies are expanding reach through mergers and acquisitions and setting up holding companies. (Click here for more - Japanese language)

Latest Headlines
See All
UsernamePublicRestriction

Register

SC067968

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel